We found 17 individuals with disease-harbouring RAD51D germline mutations, with OC at eight cases and BC at seven cases being the most frequent malignancies; all of the OCs were HGSCs, and all but one of the BCs were HER2-negative. This evidence concerns the gene ERBB2 and breast cancer.